Jennifer C. Price, MD, PhD

A. Current oral antiviral treatments include nirmatrelvir-ritonavir (Paxlovid), molnupiravir, and remdesivir

B. Nirmatrelvir-ritonavir is the only preferred oral antiviral therapy in the National Institutes of Health (NIH) treatment guidelines

C. Nirmatelvir-ritonavir and molnupiravir are each preferred oral antiviral therapies in the NIH treatment guidelines

D. The Omicron BA.5 variant is resistant to all oral antivirals